SRSF3_HUMAN - dbPTM
SRSF3_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID SRSF3_HUMAN
UniProt AC P84103
Protein Name Serine/arginine-rich splicing factor 3
Gene Name SRSF3
Organism Homo sapiens (Human).
Sequence Length 164
Subcellular Localization Nucleus . Nucleus speckle . Cytoplasm . Recruited to nuclear speckles following interaction with YTHDC1.
Protein Description Splicing factor that specifically promotes exon-inclusion during alternative splicing. [PubMed: 26876937 Interaction with YTHDC1, a RNA-binding protein that recognizes and binds N6-methyladenosine (m6A)-containing RNAs, promotes recruitment of SRSF3 to its mRNA-binding elements adjacent to m6A sites, leading to exon-inclusion during alternative splicing]
Protein Sequence MHRDSCPLDCKVYVGNLGNNGNKTELERAFGYYGPLRSVWVARNPPGFAFVEFEDPRDAADAVRELDGRTLCGCRVRVELSNGEKRSRNRGPPPSWGRRPRDDYRRRSPPPRRRSPRRRSFSRSRSRSLSRDRRRERSLSRERNHKPSRSFSRSRSRSRSNERK
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MHRDSCPL
-------CCCCCCCC
5.4420068231
5Phosphorylation---MHRDSCPLDCKV
---CCCCCCCCCCEE
20.0029255136
6S-nitrosylation--MHRDSCPLDCKVY
--CCCCCCCCCCEEE
4.552212679
10S-nitrosylationRDSCPLDCKVYVGNL
CCCCCCCCEEEEECC
4.182212679
11AcetylationDSCPLDCKVYVGNLG
CCCCCCCEEEEECCC
35.95-
11UbiquitinationDSCPLDCKVYVGNLG
CCCCCCCEEEEECCC
35.95-
11AcetylationDSCPLDCKVYVGNLG
CCCCCCCEEEEECCC
35.9523749302
13PhosphorylationCPLDCKVYVGNLGNN
CCCCCEEEEECCCCC
6.5328152594
23AcetylationNLGNNGNKTELERAF
CCCCCCCHHHHHHHH
44.78-
23UbiquitinationNLGNNGNKTELERAF
CCCCCCCHHHHHHHH
44.7821890473
23MalonylationNLGNNGNKTELERAF
CCCCCCCHHHHHHHH
44.7826320211
23AcetylationNLGNNGNKTELERAF
CCCCCCCHHHHHHHH
44.7819608861
23UbiquitinationNLGNNGNKTELERAF
CCCCCCCHHHHHHHH
44.7821890473
24PhosphorylationLGNNGNKTELERAFG
CCCCCCHHHHHHHHC
50.2120068231
28MethylationGNKTELERAFGYYGP
CCHHHHHHHHCCCCC
48.09115916745
32PhosphorylationELERAFGYYGPLRSV
HHHHHHCCCCCCEEE
9.9721945579
32NitrationELERAFGYYGPLRSV
HHHHHHCCCCCCEEE
9.97-
33PhosphorylationLERAFGYYGPLRSVW
HHHHHCCCCCCEEEE
16.7921945579
37MethylationFGYYGPLRSVWVARN
HCCCCCCEEEEEECC
32.09115916749
38PhosphorylationGYYGPLRSVWVARNP
CCCCCCEEEEEECCC
28.1922210691
57MethylationFVEFEDPRDAADAVR
EEEECCHHHHHHHHH
59.53115916753
70PhosphorylationVRELDGRTLCGCRVR
HHHCCCCEECEEEEE
31.7430624053
81PhosphorylationCRVRVELSNGEKRSR
EEEEEEECCCCCCCC
29.3220068231
85UbiquitinationVELSNGEKRSRNRGP
EEECCCCCCCCCCCC
58.0121890473
85SumoylationVELSNGEKRSRNRGP
EEECCCCCCCCCCCC
58.01-
85AcetylationVELSNGEKRSRNRGP
EEECCCCCCCCCCCC
58.0123749302
85UbiquitinationVELSNGEKRSRNRGP
EEECCCCCCCCCCCC
58.01-
85AcetylationVELSNGEKRSRNRGP
EEECCCCCCCCCCCC
58.01-
87PhosphorylationLSNGEKRSRNRGPPP
ECCCCCCCCCCCCCC
45.0029214152
90MethylationGEKRSRNRGPPPSWG
CCCCCCCCCCCCCCC
58.86115916757
95PhosphorylationRNRGPPPSWGRRPRD
CCCCCCCCCCCCCCC
48.1921712546
98MethylationGPPPSWGRRPRDDYR
CCCCCCCCCCCCCHH
38.8954559235
104PhosphorylationGRRPRDDYRRRSPPP
CCCCCCCHHHCCCCC
15.4327174698
108 (in isoform 2)Phosphorylation-39.6924275569
108PhosphorylationRDDYRRRSPPPRRRS
CCCHHHCCCCCCCCC
39.6930266825
115PhosphorylationSPPPRRRSPRRRSFS
CCCCCCCCCCHHCHH
22.4317081983
120PhosphorylationRRSPRRRSFSRSRSR
CCCCCHHCHHHHHHH
26.2620363803
122PhosphorylationSPRRRSFSRSRSRSL
CCCHHCHHHHHHHHH
30.5020363803
124PhosphorylationRRRSFSRSRSRSLSR
CHHCHHHHHHHHHHH
33.1520363803
126PhosphorylationRSFSRSRSRSLSRDR
HCHHHHHHHHHHHHH
27.7126846344
128PhosphorylationFSRSRSRSLSRDRRR
HHHHHHHHHHHHHHH
31.7626846344
130PhosphorylationRSRSRSLSRDRRRER
HHHHHHHHHHHHHHH
33.1226846344
138PhosphorylationRDRRRERSLSRERNH
HHHHHHHHHHHHHCC
26.4128355574
140PhosphorylationRRRERSLSRERNHKP
HHHHHHHHHHHCCCC
33.0828355574
148PhosphorylationRERNHKPSRSFSRSR
HHHCCCCCCCHHHHH
45.4127362937
150PhosphorylationRNHKPSRSFSRSRSR
HCCCCCCCHHHHHHC
31.7327362937
152PhosphorylationHKPSRSFSRSRSRSR
CCCCCCHHHHHHCCC
30.5027362937
154PhosphorylationPSRSFSRSRSRSRSN
CCCCHHHHHHCCCCC
33.1520068230
156PhosphorylationRSFSRSRSRSRSNER
CCHHHHHHCCCCCCC
35.5424144214
158PhosphorylationFSRSRSRSRSNERK-
HHHHHHCCCCCCCC-
41.1124144214
160PhosphorylationRSRSRSRSNERK---
HHHHCCCCCCCC---
44.2724144214

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
122SPhosphorylationKinaseAKT1P31749
PSP
128SPhosphorylationKinaseAKT1P31749
PSP
130SPhosphorylationKinaseAKT1P31749
PSP
138SPhosphorylationKinaseAKT1P31749
PSP
140SPhosphorylationKinaseAKT1P31749
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of SRSF3_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of SRSF3_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
A4_HUMANAPPphysical
21832049
U2AF2_HUMANU2AF2physical
22939629
TRA2B_HUMANTRA2Bphysical
22939629
SMU1_HUMANSMU1physical
22939629
SNUT2_HUMANUSP39physical
22939629
TR112_HUMANTRMT112physical
22939629
UT14A_HUMANUTP14Aphysical
22939629
UCRI_HUMANUQCRFS1physical
22939629
ZN454_HUMANZNF454physical
22939629
SFXN2_HUMANSFXN2physical
22939629
TOM7_HUMANTOMM7physical
22939629
VASN_HUMANVASNphysical
22939629
TAP1_HUMANTAP1physical
22939629
VPP1_HUMANATP6V0A1physical
22939629
VATE1_HUMANATP6V1E1physical
22939629
TI17A_HUMANTIMM17Aphysical
22939629
T126A_HUMANTMEM126Aphysical
22939629
SND1_HUMANSND1physical
22939629
TIA1_HUMANTIA1physical
22939629
TM14B_HUMANTMEM14Bphysical
22939629
TM177_HUMANTMEM177physical
22939629
SPG7_HUMANSPG7physical
22939629
PR38A_HUMANPRPF38Aphysical
22365833
SRSF2_HUMANSRSF2physical
22365833
TRA2B_HUMANTRA2Bphysical
22365833
IL7RA_HUMANIL7Rphysical
23151878
COPA_HUMANCOPAphysical
26344197
COPE_HUMANCOPEphysical
26344197
DDX47_HUMANDDX47physical
26344197
HEAT1_HUMANHEATR1physical
26344197
KHDR1_HUMANKHDRBS1physical
26344197
RL9_HUMANRPL9physical
26344197
4F2_HUMANSLC3A2physical
26344197
SRSF1_HUMANSRSF1physical
26344197
SRSF6_HUMANSRSF6physical
26344197
SRSF7_HUMANSRSF7physical
26344197
SRSF9_HUMANSRSF9physical
26344197
TRA2A_HUMANTRA2Aphysical
26344197
TRA2B_HUMANTRA2Bphysical
26344197

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of SRSF3_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-5, AND MASS SPECTROMETRY.
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-23, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-5, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-95, AND MASSSPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-95, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-81; SER-108; SER-138;SER-140; SER-148; SER-150 AND SER-152, AND MASS SPECTROMETRY.

TOP